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January 1993, and the early clinical and angiographic
data from the first 109 cases were published in 1996.8
We report here the 5-year clinical and angiographic
results of the first 68 consecutive surviving patients in
whom the RA was used as a free graft proximally anas-
tomosed to the aorta.
Patients and methods
Patient population. From January 1993 to February 1998,
325 patients at our institution underwent myocardial revascu-
larization with the RA as a conduit (13.4% of the isolated
coronary artery bypass procedures performed in this period).
Details of the surgical technique used have already been
described elsewhere.8 In this report we analyze the midterm
(5-year) results of the clinical and serial angiographic studies
performed on the first 68 consecutive surviving patients in
whom the RA was used as a free graft proximally anasto-
mosed to the aorta.
The main preoperative characteristics and operative data of
these 68 patients are summarized in Tables I through III. Most
of the patients were men, were in their sixth decade, and had
A fter the first disappointing experience more than 2decades ago,1 use of the radial artery (RA) in coro-
nary artery bypass grafting was again proposed by Acar
and colleagues in 1992.2 Since then many groups have
reported encouraging short-term results with this alter-
native arterial conduit.3-7 To date, however, no pub-
lished studies have examined the midterm angiographic
fate of RA grafts used for myocardial revascularization.
Our experience with the use of the RA started in
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triple-vessel coronary artery disease. The mean ejection frac-
tion was almost normal (0.67), and only 8 patients were oper-
ated on for unstable angina.
The left internal thoracic artery (ITA) was used to revascu-
larize the left anterior descending artery in 59 cases. The RA
was mainly used on the circumflex coronary artery or on the
right coronary artery. Bilateral RA harvesting was never per-
formed. Sequential RA grafts were used in 5 patients and in
1 case the RA was divided into 2 separate grafts; the overall
number of RA anastomoses performed was 74. The right ITA,
the right gastroepiploic artery, and the saphenous vein were
used to complete the myocardial revascularization. The mean
number of anastomoses per patient was 3.2.
Long-term calcium-channel blocker therapy (diltiazem at
120 mg/d administered twice a day in the slow-release form)
was prescribed at discharge from the hospital for all patients
except 2 (in whom the use of this drug led to excessive sys-
temic hypotension).
Follow-up. This study protocol was approved by the ethics
committee of the Catholic University. Informed consent was
obtained from all participating patients.
Patients were regularly followed up at our institution. They
were required to undergo stress myocardial thallium 201
scintigraphy 6 months and 1 year after the operation and then
every year thereafter. After the first year study, patients with-
out either scintigraphic evidence of ischemia in the RA terri-
tory or angiographic demonstration of occluded RA graft (n =
60) were randomly assigned to continue (29 patients) or sus-
pend (31 cases) the therapy with calcium-channel blockers.
In addition, all patients were asked to undergo a continu-
ous-wave Doppler evaluation of the forearms and an angio-
graphic study at 5 years’ follow-up. Because of the observa-
tion reported by Acar and colleagues2 that RA grafts judged
to be occluded at early angiography were found to be patent
at a successive examination, we decided that even patients
with early angiographic evidence of occluded RA grafts
should undergo angiography again at midterm.
Continuous-wave Doppler evaluation of the forearm.
Continuous-wave Doppler evaluation of the forearm was per-
formed according to a previously described method.9 The
peak systolic velocity (PSV), end-diastolic velocity, and
resistance index of the brachial artery, ulnar artery, main
artery of the thumb, and second and third common palmar
digital arteries of each arm were calculated, as were those
values for the RA of the side not operated on.
Angiographic study. Angiography was usually performed
with 5F catheters inserted through the femoral artery. A com-
plete study of the coronary arteries and of all the implanted
grafts and a left ventriculography were performed in all
patients. Attention was paid to the exact correspondence of
the different projections between the preoperative evaluation
and all the subsequent angiographic evaluations. RA graft
status at both studies was classified into 4 subgroups: (1) per-
fect patency, (2) patency with irregularities, (3) string sign
(defined as severe and extensive narrowing of the whole body
of the graft), and (4) occlusion.
In a subgroup of 19 patients the in vivo responses of the RA
and left ITA grafts to the endovascular infusion of serotonin
were evaluated in both early and midterm angiographic stud-
ies. For this purpose serotonin hydrochloride was selectively
injected into the 2 grafts at increasing concentrations (10–6
and 10–5 mol/L) at a rate of 3 mL/min for 3 minutes. At the
end of the procedure, 2 mg isosorbide dinitrate was injected
into the conduits.
All measurements on angiographic images were performed
with quantitative computerized angiography (Medis;
Amsterdam, The Netherlands). Because this system has a
lower detection limit of 0.6 mm, structures with smaller value
were considered to be 0.6 mm in diameter. Measurements of
graft diameter were always carried out about 10 mm above
the distal anastomosis and were carried out separately by 2
different observers blinded to treatment.
Statistical analysis. Data are expressed as mean ± 1 stan-
dard deviation. Categoric variables were compared by the
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Table I. Preoperative characteristics
Male/female ratio 51:17
Mean age (y) 56.8 ± 9.2
Risk factors
Diabetes 11 (16.1%)
Smoking 41 (60.2%)
Dyslipidemia 33 (42.6%)
Hypertension 29 (42.6%)
Unstable angina 8 (11.7%)
Previous AMI 44 (64.7%)
Number of diseased vessels 2.97 ± 0.51
Mean ejection fraction 0.67 ± 0.12
AMI, Acute myocardial infarction.
Table II. Operative data
CPB time (min) 63.4 ± 16.5
Aortic crossclamp time (min) 58.2 ± 19.7
Number of conduits 195
Number of distal anastomoses 224
Anastomoses per patient 3.2
Number of RA anastomoses 74*
CPB, Cardiopulmonary bypass.
*Five sequentials.
Table III. Type and distribution of distal anastomoses
LITA RITA RGEA RA SV
LAD 59 2 0 3 4
Diagonal 0 0 0 8 15
Intermediate branch 3 0 0 5 9
Circumflex 0 0 0 38 11
RCA 0 4 10 20 34
Total 62 6 10 74 73
LITA, Left ITA; RITA, right ITA; RGEA, right gastroepiploic artery; SV, saphe-
nous vein; LAD, left anterior descending coronary artery; RCA, right coronary
artery.
Fisher exact test, whereas the Student t test was used for
quantitative data. RA diameter changes in response to the
serotonin challenge were expressed as the percentage differ-
ences from the baseline values. RA diameters at baseline and
in response to 10–5 mol/L and 10–6 mol/L serotonin were
compared with 2-way analysis of variance for repeated mea-
sures. For F values with P < .05, pairwise comparisons were
then performed with the Newman-Keuls t test for paired data.
Only RA responses to the highest (vasoconstrictive) dose of
serotonin were considered in this report.
Results
Clinical results. Clinical follow-up was 100% com-
plete. Mean follow-up was 61 ± 7.5 months.
Two patients died of noncardiac causes (liver and
colon cancer 20 and 38 months after the operation,
respectively) whereas no cardiac-related deaths were
reported. Among the 66 surviving patients, 60 (90.9%)
were free of angina. Five of the 6 patients in whom
angina recurred underwent repeated angiography; 1
patient refused any invasive procedures. In the 5
patients who underwent further study, the causes of
angina were as follows: progression of the atheroscle-
rotic disease in ungrafted coronary vessels (2 cases, 23
and 31 months after the operation), stenosis of RA graft
(1 case, 54 months after the operation), occlusion of
ITA graft in the presence of patent RA graft (2 cases,
16 and 22 months after the operation).
Patients with RA stenosis and progression of the
native coronary arteries successfully underwent percu-
taneous stent angioplasty (Fig 1), whereas the 2 patients
with ITA occlusion required reoperation. All 5 patients
then underwent further studies after the surgical or per-
cutaneous procedure for the midterm follow-up.
No difference in clinical status was found between
patients who continued or suspended postoperative
therapy with calcium-channel blockers. Angina
recurred in 3 of the 29 patients who continued therapy
and in 3 of the 31 patients who suspended use of the
vasoactive drug. However, in 5 of these cases angina
recurrence was related to failure of a non-RA graft and
in only 1 case (from the continued therapy group) was
angina recurrence due to RA malfunction (P = .9).
Stress myocardial scintigraphy was performed in 61
cases; 5 patients without symptoms refused to undergo
this investigation. Scintigraphic evidence of myocar-
The Journal of Thoracic and
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Fig 1. Successful stent angioplasty of a stenosed RA graft. A, Postoperative angiography performed 54 months
after the operation demonstrated an irregular stenosis of the midtract of this RA–to–right coronary artery graft
(arrow). B, This stenosis was successfully treated by means of percutaneous stent angioplasty.
Table IV. Midterm Doppler results
Normal arm Operated arm 
(n = 35) (n = 35) P
Brachial artery
PSV 36.41 ± 9.44 38.63 ± 12.58 NS
EDV 2.90 ± 2.70 2.27 ± 2.93 NS
RI 0.92 ± 0.08 0.94 ± 0.07 NS
RA
PSV 27.87 ± 6.95 — —
EDV 4.58 ± 3.07 — —
RI 0.84 ± 0.10 — —
Ulnar artery
PSV 24.00 ± 9.89 31.75 ± 11.61 <.05
EDV 4.41 ± 3.33 6.23 ± 3.71 <.05
RI 0.82 ± 0.11 0.80 ± 0.11 NS
Main artery 
of the thumb
PSV 15.50 ± 5.47 12.91 ± 4.89 <.05
EDV 4.86 ± 4.28 4.00 ± 3.39 NS
RI 0.70 ± 0.20 0.72 ± 0.18 NS
Second common 
palmar digital artery
PSV 15.72 ± 5.35 15.30 ± 6.02 NS
EDV 4.20 ± 2.96 4.61 ± 3.30 NS
RI 0.75 ± 0.14 0.71 ± 0.18 NS
Third common 
palmar digital artery
PSV 15.17 ± 4.79 13.24 ± 3.46 <.05
EDV 4.17 ± 3.68 3.04 ± 2.80 NS
RI 0.75 ± 0.21 0.78 ± 0.14 NS
EDV, End-diastolic velocity; RI, resistance index; NS, not significant.
dial ischemia was detected in 16 of these 61 cases; 6 of
these patients had clinical angina recurrence (as
described previously), whereas 10 had asymptomatic
ischemia. Silent ischemia was due to occlusion of a
non-RA graft in 7 cases (5 saphenous veins, 1 right
ITA, and 1 gastroepiploic artery) and to failure of RA
conduit in 3 cases. In the absence of clinical ischemia,
all these cases were treated medically.
With respect to the forearm status, no cases of
ischemic hand complications were reported. However,
18 patients reported slight paresthesias (presumably
from surgical damage to minor branches of the radial
nerve) and 1 patient had tension at the elbow bend dur-
ing forearm overextension (probably related to an
excessive length of the skin incision). The remaining 47
patients (71.2%) were totally free of symptoms.
Doppler results. Doppler evaluation of the forearm
was performed in 35 patients at a mean interval of 57 ±
8.4 months after the operation. The main Doppler
results are summarized in Table IV. No important dif-
ferences were reported with respect to mean PSV, end-
diastolic velocity, and resistance index of the brachial
artery and the second common palmar digital artery
between the arm that was operated on and the con-
tralateral arm.
The mean PSV and end-diastolic velocity of the ulnar
artery were higher in the arm that was operated on
(expressing the ulnar compensation for RA removal).
The mean PSV of the main artery of the thumb and that
of the third common palmar digital artery were lower in
the arm that was operated on.
A flow gradient between the arteries of the hand of
the arm that was operated on (flow higher in the medi-
al and lower in the lateral arteries) had been seen 1 year
after the operation, as has been described elsewhere.9
This gradient had disappeared at 5 years’ follow-up. At
that time the PSVs in the main artery of the thumb and
the second and third common palmar digital arteries
were almost equivalent between the 2 arms.
Angiographic results. Midterm angiographic stud-
ies were performed in 61 of the 66 cases. Four patients
refused any invasive procedure (3 of these had no
symptoms and the fourth had Canadian Cardiovascular
Society class III effort angina and scintigraphic evi-
dence of ischemia in the distribution of a saphenous
vein graft). One patient was excluded because of rapidly
deteriorating renal function. As in 1 patient the RA was
divided in 2 separate conduits, a total of 62 RA grafts
were investigated. The mean interval between opera-
tion and angiography was 59 ± 6.5 months.
The main angiographic results are reported in Table V.
The perfect patency rate of the RA was 87.0% (54/62),
compared with 68.9% for the saphenous vein and
98.2% for the left ITA (P = .4 and P = .7, respectively).
A string sign of RA grafts was reported in 2 cases.
Among the 61 cases restudied, 48 patients (49 grafts)
had previously undergone early angiographic study
within 1 year after the operation (mean interval 11.1 ±
2.7 months).8 The comparison between the 2 angio-
graphic studies performed in these 48 patients 1 and 5
years after the operation demonstrated that all RA
grafts that were patent early after the operation
remained patent at midterm follow-up (Table VI).
Parietal irregularities of the proximal part of the RA
graft (in close proximity to the aortic anastomosis)
revealed in 7 cases by early angiography had disap-
peared after 5 years, and in 1 case the RA was judged
1018 Possati et al The Journal of Thoracic and
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Table V. Midterm angiographic results
LITA (n = 58*) RITA (n = 4) RGEA (n = 10) RA (n = 62†) SV (n = 58)
No. % No. % No. % No. % No. %
Perfectly patent 57* 98.2 3 75 8 80 54 87.0 40 68.9
Patent with irregularities 0 0 0 0 0 0 1 1.6 3 5.1
String sign 1 1.7 0 0 1 10 2 3.2 0 0
Occluded 0 0 1 25 1 10 5 8.0 15 25.8
LITA, left ITA; RITA, right ITA; RGEA, right gastroepiploic artery; SV, saphenous vein.
*Excluding the 2 patients reoperated on within 2 years after the operation because of ITA occlusion.
†Including the patient who underwent stent angioplasty 54 months after the operation.
Table VI. Comparison between the early and midterm
angiographic studies in 48 cases
Early Midterm 
angiographic angiographic 
control control
RA graft status No. % No. % P
Perfectly patent 33 67.3 41 83.6 .1
Patent with irregularities 8 16.3 1 2.0 .03
String sign 2 4.0 2 4.0 .6
Occluded 6 12.2 5 10.2 1.0
to be occluded after 1 year but was found to be widely
patent at midterm study (Figs 2 and 3). For these rea-
sons the perfect patency rate of RA grafts increased
from 67.3% to 83.6% between the first angiographic
study and the second (Table VI). Moreover, the mean
caliber of the RA grafts increased markedly between
the 2 angiographic studies, from 2.09 ± 0.51 mm at 1
year after the operation to 2.58 ± 0.63 mm at 5 years’
follow up (P < .001).
The analysis of RA graft status at 5 years with
respect to the degree of stenosis of the target vessel on
preoperative angiography demonstrated that 5 of the 6
RAs used to graft target vessels with subcritical
stenoses (≤70%) had string sign (1 case) or occlusion
(4 cases) at midterm follow-up (Fig 4). These 5 failures
accounted for most of the overall cases of RA mal-
function. The only case of occlusion among the
patients in whom the RA was anastomosed to a vessel
with stenosis greater than 70% was reported for a
patient who had a severe mediastinitis early after the
operation and underwent complete sternectomy and
chest closure with a pectoralis major muscle flap.
The study of RA and left ITA responses to the
endovascular infusion of serotonin was performed
within 1 year after the operation in 19 cases.8 In 15 of
these 19 cases, the same study was repeated at 5 years’
follow-up. Comparison of results between the early and
midterm studies showed that the vasoreactivity of RA
grafts varied markedly between the first and the second
angiographic investigations. In fact, early after the
operation serotonin infusion led to a marked vasocon-
striction of RA grafts (greater than that reported in the
left ITA in the same patient), whereas after 5 years
serotonin at the same doses elicited only minor RA
constriction (similar to that reported in the ITA graft in
the same patient; Table VII).
Finally, no difference in RA graft status could be
demonstrated between patients who continued or sus-
pended calcium-channel blocker therapy 1 year after
the operation. In fact, 1 string sign was reported among
the patients who suspended the calcium-channel antag-
onists, whereas 1 RA with string sign and 1 graft with
irregularities were found in the group that continued
therapy (P = .5 and .9, respectively).
Discussion
Despite the good early clinical and angiographic
results reported,2-7 little is known about the results of
RA grafts at midterm follow-up. The effective role of
this conduit in coronary surgery and its relative value
with respect to other arterial grafts and to venous grafts
have not yet received objective clarification. The excel-
lent overall survival and cardiac death–free survival 5
years after the operation testify to the good cardiologic
and systemic status and the relatively young age of this
population consequent to our policy of using RA grafts
in young patients in good condition, who provide the
optimal clinical setting for the evaluation of a new arte-
rial conduit and who are expected to receive the maxi-
mal benefit from arterial revascularization.
In our experience the overall and perfect patency
rates of RA grafts at 5 years’ follow-up (91.9% and
The Journal of Thoracic and
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Fig 2. Patent RA graft at 5 years’ follow up. It is noteworthy that
control angiography performed within 1 year after the operation
documented an occluded RA–to–left anterior descending coro-
nary artery graft, whereas repeated angiography at 5 years’ fol-
low-up demonstrated a widely patent conduit.
Table VII. Comparison between the early and midterm
responses to serotonin infusion
RA LITA
1-y study
Baseline mean diameter (mm) 2.11 ± 0.10 2.42 ± 0.05
Mean diameter with serotonin 1.70 ± 0.37 2.41 ± 0.17
(mm)
Constriction (%) 18.91 ± 8.40* 0.41 ± 0.22†
5-y study
Baseline mean diameter (mm) 2.58 ± 0.37 2.53 ± 0.17
Mean diameter with serotonin 2.48 ± 0.72 2.45 ± 0.14
(mm)
Constriction (%) 3.94 ± 1.92‡§ 3.21 ± 0.84 II
LITA, Left ITA.
*P < .001 compared with baseline and with left ITA constriction at the same
time.
†P not significant compared with baseline.
‡P not significant compared with baseline and with left ITA constriction at the
same time.
§P < .001 compared with RA constriction at 1 year.
IIP not significant compared with baseline and with left ITA constriction at 1 year.
87.0%, respectively) were slightly inferior to those
achieved with the left ITA (100% patency rate and
98.2% perfect patency rate). However, because the left
ITA was always used to graft the left anterior descend-
ing coronary artery (Table III), whereas the RA was
usually anastomosed to secondary target vessels, the
comparison of the angiographic results of these 2 con-
duits is marred by an obvious selection bias. In con-
trast, the saphenous vein had a target-vessel pattern
more similar to that of the RA (Table III), so the com-
parison of the angiographic patency rates of these 2
conduits is probably more meaningful. Five years after
the operation, the patency and perfect patency rates of
the saphenous vein grafts were 74.1% and 68.9%,
respectively. These rates are consistent with those
reported in most angiographic series10-12 and inferior to
those achieved with the RA.
The serial angiographic study performed in the 48
patients who underwent both early and midterm repeat-
ed angiographic evaluation demonstrated that most of
the parietal irregularities observed in RA grafts 1 year
after the operation had disappeared at 5 years’ follow-
up, leading to an evident increase of the midterm per-
fect patency rate (Table VI). This observation led us to
hypothesize that the abnormalities seen at early angiog-
raphy were due to focal conduit spasm (rather than
organic lesions), which resolved at midterm follow-up
as a result of progressive loss of the RA hyperreactivi-
ty. In fact, although a high propensity toward spasm of
RA grafts in the early postoperative period was demon-
strated by our group in vivo13 and episodes of spasm
are reported in almost all the short-term angiographic
series, until now no data on the modification with time
of the RA vasoreactivity have been published.
In the subgroup of patients who underwent endovascu-
lar administration of serotonin at both the early and
midterm angiographic studies, we observed a marked
reduction in the contractile response of RA grafts. RA
grafts had become almost insensitive to serotonin by 5
years’ follow-up (Table VII). Concordantly, we observed
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Fig 4. Status of RA grafts with respect to preoperative target-vessel stenosis.
Fig 3. Resolution of RA parietal irregularities between the first and the second angiographic studies. A, One year
after the operation, angiography documented evident irregularities of the proximal part of this RA graft (arrow).
B, Five years after the operation, repeated angiography demonstrated the resolution of these parietal irregulari-
ties, leading to a perfectly patent graft.
that both the clinical results and the midterm angiographic
statuses of the RA grafts were not influenced by the use of
calcium-antagonists after the first postoperative year.
In recent years several experimental and angiographic
observations have underscored the importance of the site
of the proximal anastomosis of the free grafts.4,14 It has
been hypothesized that RA grafts proximally anasto-
mosed to the ascending aorta are particularly vulnerable
to the development of fibrous intimal hyperplasia
because of the high wall stress to which they are
exposed.4 In fact, intimal hyperplasia was proposed as the
main cause of the high rate of RA failure in the 1970s.15
Our series shows that the angiographic results of RA
grafts anastomosed to the aorta are excellent. Moreover,
the evident increase with the time of RA graft diameter
seems to deny the possibility of the development of a
more than trivial degree of intimal hyperplasia. In addi-
tion our study testifies to the influence of the severity of
target-vessel stenosis on the midterm patency of RA
grafts. In fact, in our experience 4 of the 5 occlusions and
1 of the 2 string signs occurred during the first year in
patients in whom the RA was used to revascularize a
vessel with subcritical (<70%) stenosis, whereas the con-
duits anastomosed to severely stenotic arteries had
clearly superior patency and perfect patency rates (Fig 4).
It seems then likely that, in contrast to what has been
reported for other conduits,16 chronic native flow com-
petition in the early postoperative period (when the RA
is highly reactive, despite therapy with calcium-chan-
nel blockers)13 can lead to RA graft malfunction and
even failure (presumably from persistent graft spasm).
In subsequent years the progressive loss of RA hyper-
reactivity can probably lead to spasm resolution and
thus to disappearance of conduit irregularities and even
reopening of previously closed grafts.
Finally, most patients are free of hand complications 5
years after the operation. Doppler studies of the forearm
demonstrated that the removal of the RA was compensat-
ed for by an anastomotic network from the ulnar artery.
Our data show that the midterm angiographic results
of RA grafts used for myocardial revascularization are
excellent, superior to those achieved with the saphenous
vein. A correct surgical indication (the use of this con-
duit to revascularize only vessels with severe stenoses)
is essential. Continued therapy with calcium-channel
antagonists after the first year and the performance of
the proximal anastomosis to the ascending aorta do not
influence the midterm angiographic status of RA grafts.
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